Health Empowerment Program to Improve Health Information Literacy and Outcomes in Adults with Metabolic Syndrome
Led by Meihua Ji · Updated on 2025-12-01
310
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
This research aims to evaluate how a health information literacy promotion program based on Health Empowerment Theory affects individuals with metabolic syndrome. The study focuses on whether this intervention improves participants understanding of health information and leads to better health outcomes such as weight, waist size, BMI, blood pressure, blood sugar, glycated hemoglobin, and blood lipids.
Participants are divided into two groups one group receives a 6-week intervention program involving weekly 30 to 40-minute sessions that include training on health information literacy, medication management, self-monitoring skills, diet and exercise education, personalized goal setting, peer support, and digital health monitoring. The other group receives routine health education materials and weekly health knowledge updates via WeChat groups.
Throughout the study, participants will be regularly assessed before, immediately after, and at 3 and 6 months following the intervention to measure changes in their health information literacy, self-management abilities, metabolic health markers, physical exams, and quality of life. Monitoring includes questionnaires, physical measurements, and blood tests to track the interventions impact over time.
CONDITIONS
Brief Title
Efficacy of a Health Empowerment Theory Based Health Information Literacy Promotion Intervention in Individuals With Metabolic Syndrome
Research Team
M
Meihua Ji
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
The Luhe Teaching Hospital of the Capital Medical University
Collaborating Sponsor
Who Can Participate
Age: 18Years - 75Years
All Genders
Eligibility Criteria
You may qualify if you...
Adults aged 18 to 75 years
Diagnosed with metabolic syndrome meeting at least three of the following: waist circumference ≥ 90 cm for men or ≥ 85 cm for women, fasting glucose ≥ 6.1 mmol/L or 2-hour glucose ≥ 7.8 mmol/L or on diabetes treatment, blood pressure ≥ 130/85 mmHg or on hypertension treatment, fasting triglycerides ≥ 1.70 mmol/L, fasting HDL-C < 1.04 mmol/L
Aware of their condition with basic reading and communication skills
Voluntarily agree to participate in the study
You will not qualify if you...
Severe liver or kidney dysfunction, cancer, severe cardiovascular or cerebrovascular diseases, gout, or other life-threatening conditions requiring special diet
Pregnant individuals
History of mental illness or cognitive impairment
Currently participating in other research studies
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Behavioral Intervention
Duration - 6 weeks
Participants in the ENRICH group will undertake a six-week program including health information literacy training, medication management skills, self-monitoring practice, diet and exercise education, personalized goal setting, behavioral incentives, peer support, role model demonstrations, and support via online groups and digital platforms.
Once a week intervention sessions lasting 30-40 minutes
Routine Care Observation
Duration - 6 weeks
Participants in the routine care group receive weekly health education via distributed materials and WeChat groups covering topics such as health information screening, medicine knowledge, self-monitoring, exercise, and dietary knowledge over six weeks.
Weekly distribution of health education materials for 6 weeks
Follow-up Monitoring
Duration - Up to 6 months after intervention start
Participants undergo follow-up assessments to measure health information literacy, self-management, metabolic and physical health indicators at baseline, immediately post-intervention, and at 3 and 6 months after the start of the intervention.
4 assessment visits: baseline, end of intervention, 3 months, and 6 months
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Phase 3 Study of Obicetrapib 10 mg and Ezetimibe 10 mg Combination or Obicetrapib Alone Added to Standard Lipid-Lowering Treatment in Adults With Type 2 Diabetes or Metabolic Syndrome
Randomized Comparison of a Healthy Beef-Centered Diet Versus a USDA-Style Healthy Diet on Inflammation and Metabolic Health in Adults with Metabolic Syndrome or Pre-Diabetes
Community-Based Health Coaching and AI-Powered Digital Program to Improve Diet and Heart Health in Adults With Metabolic Syndrome
Health Empowerment Program to Improve Health Information Literacy and Outcomes in Adults with Metabolic Syndrome
Effects of Temporarily Stopping Metformin on Insulin Sensitivity and Glucose Control in Adults With Metabolic Syndrome
Lifestyle Program of Dietary Counseling and Exercise to Reduce Heart Disease Risk in Norwegian Adults with Severe Mental Illness
Study on How Higher Blood Lactate Levels Affect Fat and Sugar Metabolism in Adults With and Without Metabolic Syndrome
Studying Multi-omics to Understand and Predict Metabolic Syndrome and Related Diseases for Better Personalized Care
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Associations of patient health-related problem solving with disease control, emergency department visits, and hospitalizations in HIV and diabetes clinic samples.